Search Results - "Singh, Gunjesh Kumar"

A real‐world data of Immune checkpoint inhibitors in solid tumors from India by Noronha, Vanita, Abraham, George, Patil, Vijay, Joshi, Amit, Menon, Nandini, Mahajan, Abhishek, Janu, Amit, Jain, Srushti, Talreja, Vikas T, Kapoor, Akhil, Kumar Singh, Gunjesh, Khaddar, Satvik, Gupta, Kushal, Rathinasamy, Narmadha, Srinivas, Sujay, Agrawal, Amit, Ventrapati, Pradeep, Prabhash, Kumar

“…Background Checkpoint inhibitors (Nivolumab and Pembrolizumab) are approved for multiple indications in solid tumors. However access to these therapies is…”
Get full text

Bendamustine in the third line or beyond in metastatic, recurrent, or relapsed head-and-neck cancers: A retrospective observational study by Patil, Vijay, Adak, Supriya, Noronha, Vanita, Menon, Nandini, Singh, Gunjesh, Prabhash, Kumar

“…Background: Head-and-neck squamous cell carcinoma (HNSCC) is one of the most aggressive malignant tumors and is commonly diagnosed at an advanced stage. In the…”
Get full text

Excellent response to erlotinib in breast carcinoma with rare EGFR mutation—a case report by Kumar Singh, Gunjesh, Bajpai, Jyoti, Joshi, Shalaka, Prabhash, Kumar, Choughule, Anuradha, Patil, Asawari, Gupta, Sudeep, Achyut Badwe, Rajendra

“…Triple negative breast carcinoma is a problematic subtype with poor outcomes. Many clinical trials are underway to find possible target to increase treatment…”
Get full text

Cancer-related fatigue and its impact on quality of life in patients with central nervous system tumors: A cross-sectional analysis by Gunjesh Kumar Singh, Litty Varghese, Nandini Menon, Ochin Dale, Vijay M Patil

“…Background: Cancer-related fatigue (CRF) has a high prevalence in individuals with cancer, especially in those with central nervous system (CNS) tumors, and…”
Get full text

Lymphopenia during chemoradiation-foe or friend by Patil, Vijay M, Singh, Gunjesh Kumar, Noronha, Vanita, Joshi, Amit, Menon, Nandini, Lashkar, Sarbani Ghosh, Mathrudev, Vijayalakshmi, Satam, Kavita Nawale, Mukadam, Sadaf Abdulazeez, Prabhash, Kumar

“…Severe lymphopenia during treatment is considered to be a poor prognostic factor. The current literature lacks information regarding its impact on various…”
Get full text

Lung metastasis in primary cutaneous adenoid cystic carcinoma – Clinicopathological evaluation of a rare case with review of literature by Singh, Gunjesh Kumar, Singh, Pragya, Kaur, Jaspreet, Kumar, Rakesh

“…Primary cutaneous adenoid cystic carcinoma (ACC) is an extremely rare and indolent cutaneous malignancy with very infrequent distant metastasis. We present a…”
Get full text

Cytological diagnosis of a rare case of cutaneous metastasis from transitional cell carcinoma, renal pelvis by Singh, Pragya, Kolte, Sachin, Singh, Gunjesh Kumar

“…Transitional cell carcinoma (TCC) arising from renal pelvis rarely gives rise to cutaneous metastasis. Due to the insufficient literature, the exact incidence…”
Get full text

Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy by Singh, Gunjesh Kumar, Capoor, Malini R., Nair, Deepthi, Bhowmik, K.T.

“…Radiotherapy for head and neck cancers (HNC) causes alteration of oral mucosal barrier predisposing it to colonization and infection. Such infections often…”
Get full text

Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis by Noronha, Vanita, Patil, Vijay M, Singh, Gunjesh Kumar, Joshi, Amit, Menon, Nandini, Lashkar, Sarbani Ghosh, Mathrudev, Vijayalakshmi

“…Background Acute oral mucositis has been infrequently studied in the patients with head and neck squamous cell carcinoma (HNSCC) receiving once-weekly…”
Get full text

A Survey of Satisfaction with Treatment among Brain Tumor Patients by Singh, Gunjesh Kumar, Alone, Mitali, Menon, Nandini, Dale, Ochin, Bhelekar, Arti, Patil, Vijay M.

Get full text

Safety and efficacy of concurrent chemoradiotherapy for head-and-neck cancers in older versus younger patients: Post hoc analysis of a randomized controlled trial by Gunjesh Kumar Singh, Vanita Noronha, Vijay Maruti Patil, Nandini Menon, Amit Joshi, Kumar Prabhash

“…Background: Head-and- neck squamous cell carcinoma (HNSCC) is a commonly occurring malignancy in the geriatric population. However, there is a scarcity of data…”
Get full text

Aprepitant for patients with head-and-neck cancer receiving once-a-week cisplatin with radiation: Is it required? by Vanita Noronha, Hollis D'souza, Amit Kumar Choudhary, Vijay M Patil, Gunjesh Kumar Singh, Amit Joshi, Nandini Menon, Kumar Prabhash

Get full text

Multiple cutaneous metastases in a patient of carcinoma tonsil – Report of a rare case by Singh, Gunjesh Kumar, Yadav, Vikas, Singh, Pragya, Bhowmik, K.T.

“…Carcinoma tonsil with visceral metastasis is a rare entity, and cutaneous metastasis is seen even more infrequently. We present a case of a 55-year-old male…”
Get full text

Cognitive score in patients with primary brain tumors undergoing systemic therapy – a cross-sectional study by Supriya Adak, Gunjesh Kumar Singh, Nandini Menon, Ochin Dale, Sujay Srinivas, Sudeep Das, Somnath Roy, Dilip Harindran Vallathol, Vijay Maruti Patil

“…Background: The systemic treatment of brain tumors is complex. Apart from the disease burden and adverse effects of systemic therapy, cognitive decline of…”
Get full text

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study by Patil, Vijay Maruti, Noronha, Vanita, Menon, Nandini, Rai, Rahul, Bhattacharjee, Atanu, Singh, Ajay, Nawale, Kavita, Jogdhankar, Shweta, Tambe, Rupali, Dhumal, Sachin, Sawant, Riddhi, Alone, Mitali, Karla, Devanshi, Peelay, Zoya, Pathak, Shruti, Balaji, Arun, Kumar, Suman, Purandare, Nilendu, Agarwal, Archi, Puranik, Ameya, Mahajan, Abhishek, Janu, Amit, Kumar Singh, Gunjesh, Mittal, Neha, Yadav, Subhash, Banavali, Shripad, Prabhash, Kumar

“…The regimens approved for the treatment of advanced head and neck squamous cell carcinoma are accessible to only 1%-3% of patients in low- and middle-income…”
Get full text

Metronomic systemic PCm (paclitaxel, carboplatin + metronomic) neoadjuvant chemotherapy in head and neck cancer by Singh, Gunjesh Kumar, Prabhash, Kumar, Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Menon, Nandini Sharrel, Singh, Pragya, Qayyumi, Burhanuddin, Singh, Ravikant

“…e18073 Background: Neoadjuvant chemotherapy (NACT) in head and neck cancers (HNC) with taxane, platinum, 5-FU (TPF) regimen is both toxic as well as difficult…”
Get full text

Second malignancy post-chemoradiation in head and neck cancer patients by Singh, Gunjesh Kumar, Swami, Rohit, Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Menon, Nandini Sharrel, Prabhash, Kumar

“…Abstract only e18525 Background: There is limited data available in the literature regarding incidence and treatment of second malignancy post-chemo-radiation…”
Get full text

Weight loss and its impact on outcome in head and cancer patients during chemo-radiation by Singh, Gunjesh Kumar, Patil, Vijay M., Noronha, Vanita, Joshi, Amit, Menon, Nandini, Lashkar, Sarbani Ghosh, Mathrudev, Vijayalakshmi, Satam, Kavita Nawale, Prabhash, Kumar

“…•In both arms, there was no weight loss (grade 0) at baseline.•Grade 1 weight loss was seen in 36.6%, grade 2 in 18.3% and grade 3 in 1% patients.•2-year PFS…”
Get full text

Phase 3 randomized study for evaluation of physician choice Rx and triple metronomic as second-line therapy in head and neck cancer (CRSF 2021-HN-001) by Kothari, Rushabh Kiran, Ravikrishna, Madala, Singh, Ravikant, Talreja, Vikas, Pathak, Anand Bhaskarrao, Shrirangwar, Sameer, Mandal, Tanmoy Kumar, Das, Sudeep, Turkar, Siddharth, Pande, Nikhil, Chandrasekharan, Arun, Singh, Gunjesh Kumar, Gupta, Tara Chand, Karpe, Ashay, Poladia, Bhavesh Pradip, Avaronnan, Manuprasad, Wilson, Lovin, Raut, Nirmal Vivek, Patil, Vijay Maruti, Prabhash, Kumar

“…LBA6004 Background: There are multiple options of treatment in second-line therapy in locally advanced head and neck squamous cell carcinoma (LAHNSCC) with…”
Get full text

Safety and efficacy of bevacizumab biosimilar in glioma by Singh, Gunjesh Kumar, D'souza, Hollis, Srinivas, Sujay, Vallathol, Dilip Harindran, Boppana, Mounika, Rajpurohit, Annu, Mahajan, Abhishek, Janu, Amit, Chatterjee, Abhishek, Krishnatry, Rahul, Gupta, Tejpal, Jalali, Rakesh, Patil, Vijay Maruti

“…Abstract only e14541 Background: Anti-VEGF antibody Bevacizumab (Avastin: Roche Pharma AG) is the recommended drug for recurrent glioma. Multiple low-cost…”
Get full text